Clinical Trial Update: Hippocampus-sparing WBRT and Simultaneous Integrated Boost for Multiple Brain Metastases From NSCLC [Phase 2]

View source ↗

Summary

This Phase 2 trial investigates hippocampus-sparing whole-brain radiotherapy with a simultaneous integrated boost for brain metastases from non-small cell lung …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Non-small Cell Lung Cancer

Snippet

Sponsor: Samsung Medical Center | Conditions: Brain Metastases | Phase 2 | Status: UNKNOWN